507 related articles for article (PubMed ID: 33207810)
1. Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression.
Sinha D; Saha P; Samanta A; Bishayee A
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33207810
[TBL] [Abstract][Full Text] [Related]
2. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
Garg M
Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
[TBL] [Abstract][Full Text] [Related]
3. Hybrid Epithelial/Mesenchymal State in Cancer Metastasis: Clinical Significance and Regulatory Mechanisms.
Liao TT; Yang MH
Cells; 2020 Mar; 9(3):. PubMed ID: 32143517
[TBL] [Abstract][Full Text] [Related]
4. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.
Qi XK; Han HQ; Zhang HJ; Xu M; Li L; Chen L; Xiang T; Feng QS; Kang T; Qian CN; Cai MY; Tao Q; Zeng YX; Feng L
Theranostics; 2018; 8(8):2202-2216. PubMed ID: 29721073
[No Abstract] [Full Text] [Related]
5. Epigenetic regulation of hybrid epithelial-mesenchymal cell states in cancer.
Sample RA; Nogueira MF; Mitra RD; Puram SV
Oncogene; 2023 Jul; 42(29):2237-2248. PubMed ID: 37344626
[TBL] [Abstract][Full Text] [Related]
6. Coupling the modules of EMT and stemness: A tunable 'stemness window' model.
Jolly MK; Jia D; Boareto M; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
Oncotarget; 2015 Sep; 6(28):25161-74. PubMed ID: 26317796
[TBL] [Abstract][Full Text] [Related]
7. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
Jolly MK; Somarelli JA; Sheth M; Biddle A; Tripathi SC; Armstrong AJ; Hanash SM; Bapat SA; Rangarajan A; Levine H
Pharmacol Ther; 2019 Feb; 194():161-184. PubMed ID: 30268772
[TBL] [Abstract][Full Text] [Related]
8. Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression.
Lee JY; Kong G
Cell Mol Life Sci; 2016 Dec; 73(24):4643-4660. PubMed ID: 27460000
[TBL] [Abstract][Full Text] [Related]
9. Stability of the hybrid epithelial/mesenchymal phenotype.
Jolly MK; Tripathi SC; Jia D; Mooney SM; Celiktas M; Hanash SM; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
Oncotarget; 2016 May; 7(19):27067-84. PubMed ID: 27008704
[TBL] [Abstract][Full Text] [Related]
10. Towards elucidating the connection between epithelial-mesenchymal transitions and stemness.
Jolly MK; Huang B; Lu M; Mani SA; Levine H; Ben-Jacob E
J R Soc Interface; 2014 Dec; 11(101):20140962. PubMed ID: 25339690
[TBL] [Abstract][Full Text] [Related]
11. The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links.
Liu X; Fan D
Curr Pharm Des; 2015; 21(10):1279-91. PubMed ID: 25506898
[TBL] [Abstract][Full Text] [Related]
12. Involvement of partial EMT in cancer progression.
Saitoh M
J Biochem; 2018 Oct; 164(4):257-264. PubMed ID: 29726955
[TBL] [Abstract][Full Text] [Related]
13. A role for partial epithelial-to-mesenchymal transition in enabling stemness in homeostasis and cancer.
Verstappe J; Berx G
Semin Cancer Biol; 2023 May; 90():15-28. PubMed ID: 36773819
[TBL] [Abstract][Full Text] [Related]
14. A Computational Systems Biology Approach Identifies SLUG as a Mediator of Partial Epithelial-Mesenchymal Transition (EMT).
Subbalakshmi AR; Sahoo S; Biswas K; Jolly MK
Cells Tissues Organs; 2022; 211(6):689-702. PubMed ID: 33567424
[TBL] [Abstract][Full Text] [Related]
15. NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype.
Bocci F; Tripathi SC; Vilchez Mercedes SA; George JT; Casabar JP; Wong PK; Hanash SM; Levine H; Onuchic JN; Jolly MK
Integr Biol (Camb); 2019 Jun; 11(6):251-263. PubMed ID: 31329868
[TBL] [Abstract][Full Text] [Related]
16. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
Liao TT; Yang MH
Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
[TBL] [Abstract][Full Text] [Related]
17. SCAND1 Reverses Epithelial-to-Mesenchymal Transition (EMT) and Suppresses Prostate Cancer Growth and Migration.
Eguchi T; Csizmadia E; Kawai H; Sheta M; Yoshida K; Prince TL; Wegiel B; Calderwood SK
Cells; 2022 Dec; 11(24):. PubMed ID: 36552758
[TBL] [Abstract][Full Text] [Related]
18. NFATc Acts as a Non-Canonical Phenotypic Stability Factor for a Hybrid Epithelial/Mesenchymal Phenotype.
Subbalakshmi AR; Kundnani D; Biswas K; Ghosh A; Hanash SM; Tripathi SC; Jolly MK
Front Oncol; 2020; 10():553342. PubMed ID: 33014880
[TBL] [Abstract][Full Text] [Related]
19. EMT Transition States during Tumor Progression and Metastasis.
Pastushenko I; Blanpain C
Trends Cell Biol; 2019 Mar; 29(3):212-226. PubMed ID: 30594349
[TBL] [Abstract][Full Text] [Related]
20. Regulation of epithelial-mesenchymal transition through SUMOylation of transcription factors.
Bogachek MV; De Andrade JP; Weigel RJ
Cancer Res; 2015 Jan; 75(1):11-5. PubMed ID: 25524900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
